In the previous post we discussed the effects of the project meeting in Paris regarding the everyday cooperation of the partners. Nevertheless this was by no means the only interesting aspect of the event. The content of the meeting itself and the quality additions to our team were the real issues of interest.

As a consortium, after an initial phase of requirements, we have made some progress in the understanding and initial developments of some of the core technologies of the project. Some of the main issues discussed where the architecture of the decision support system, its visual appearance, the information provided by imaging modalities, the role of genetics, the availability of data and the required validation protocols.

What is more, we have to underline the relevant presence for the first time of members of the Project Advisory Board. Drs Isabel Alvarez, Stuart McIntosh and Antonio Piñero, all experienced clinicians that know the specific needs of a Breast Unit and Nicole Zernik representing Europa Donna bringing the know-how and the perspective of the end user, all made it clear from the very beginning that their contribution will be extremely valuable.

They were able to understand the project aims, to put up with the current and future project developments and provide their views into the project objectives, offering advice and pointing out some specific issues necessary to keep into account for a successful endeavor. Among these we could mention the doctor requirements and patient needs, the shortcomings regarding data analytics and presentation of cases in the breast units, the possible role of imaging and genetics in breast cancer management, the possible use cases for radiobiological modelling or the need of development of interoperable solutions. We were delighted in any case to hear their positive views about the project and the hope that we could really successfully achieve what we are aiming at.